Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Azetukalner, an experimental Kv7 potassium-channel opener, with placebo for people with bipolarity. Participants receive Azetukalner or placebo and complete study visits and assessments.
This study is comparing Abilify 2, 5, 10, 15mg (Tablet) with placebo for people with Depression, Bipolar. Participants receive Abilify 2, 5, 10, 15mg (Tablet) or placebo and complete study visits and assessments.
This study is comparing Brenipatide with placebo for people with bipolarity. Participants receive Brenipatide or placebo and complete study visits and assessments.
This observational study is following people with bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with bipolarity or Frontotemporal Dementia, Behavioral Variant to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with psychosis or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at assess how safe and effective Icalcaprant is in treating adult participants with bipolar I or II disorder for people with Bipolarity I or Bipolarity II. Participants receive Icalcaprant or placebo and complete study visits and assessments.
This study is comparing Cariprazine with placebo for people with Depression or Bipolarity I. Participants receive Cariprazine or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with bipolarity Type I With Mania. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with depression, psychosis, or bipolarity. Taking part may give some people access to Valbenazine, but direct benefit is not guaranteed.
This study is looking at evaluate the efficacy and safety of adjunctive KarXT for the treatment of mania in participants with Bipolarity type I for people with Mania or bipolarity. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolarity type I for people with Bipolarity type I With Mania or Mania With Mixed Features. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with bipolarity Type I With Mania or Mania With Mixed Features to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether psychoeducation can help people with bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Bipolarity II, Most Recent Episode Major Depressive, Current Depressive Episode, or Treatment Resistant Depression. Some participants may receive Sham aiTBS instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether questionnaires and follow-up can help people with Bipolarity II, Depression, Bipolar, or Suicidality. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia, bipolarity, major depression, or Stress Disorder, Post-Traumatic. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with bipolarity, Alcohol Drinking, or Alcohol Use Disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) with placebo for people with Treatment-resistant Depression in bipolarity. Participants receive Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Bipolarity I or Mania. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with depression or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Apathy or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Schizophrenia, bipolarity, Metabolic Syndrome, or Overweight and Obesity. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This observational study is following people with bipolarity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.